52 related articles for article (PubMed ID: 16177479)
1. Elongated beamlets: a simple technique for segment and MU reduction for sMLC IMRT delivery on accelerators utilizing 5 mm leaf widths.
Price RA; Paskalev K; McNeeley S; Ma CM
Phys Med Biol; 2005 Oct; 50(19):N235-42. PubMed ID: 16177479
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
Lee EK; Fox T; Crocker I
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
[TBL] [Abstract][Full Text] [Related]
3. Using total-variation regularization for intensity modulated radiation therapy inverse planning with field-specific numbers of segments.
Zhu L; Lee L; Ma Y; Ye Y; Mazzeo R; Xing L
Phys Med Biol; 2008 Dec; 53(23):6653-72. PubMed ID: 18997262
[TBL] [Abstract][Full Text] [Related]
4. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
5. Impact of pelvic nodal irradiation with intensity-modulated radiotherapy on treatment of prostate cancer.
Price RA; Hannoun-Levi JM; Horwitz E; Buyyounouski M; Ruth KJ; Ma CM; Pollack A
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):583-92. PubMed ID: 16966000
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
Kassim I; Dirkx ML; Heijmen BJ
Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
[TBL] [Abstract][Full Text] [Related]
7. A comparison of conformal and intensity modulated treatment planning techniques for early prostate cancer.
Vaarkamp J; Malde R; Dixit S; Hamilton CS
J Med Imaging Radiat Oncol; 2009 Jun; 53(3):310-7. PubMed ID: 19624299
[TBL] [Abstract][Full Text] [Related]
8. RapidArc volumetric modulated therapy planning for prostate cancer patients.
Kjaer-Kristoffersen F; Ohlhues L; Medin J; Korreman S
Acta Oncol; 2009; 48(2):227-32. PubMed ID: 18855157
[TBL] [Abstract][Full Text] [Related]
9. Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer?
Sanguineti G; Cavey ML; Endres EJ; Brandon GG; Bayouth JE
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):151-60. PubMed ID: 16198066
[TBL] [Abstract][Full Text] [Related]
10. The feasibility of using Pareto fronts for comparison of treatment planning systems and delivery techniques.
Ottosson RO; Engstrom PE; Sjöström D; Behrens CF; Karlsson A; Knöös T; Ceberg C
Acta Oncol; 2009; 48(2):233-7. PubMed ID: 18752085
[TBL] [Abstract][Full Text] [Related]
11. Dosimetry limitations and a dose correction methodology for step-and-shoot IMRT.
Grigorov GN; Chow JC; Barnett RB
Phys Med Biol; 2006 Feb; 51(3):637-52. PubMed ID: 16424586
[TBL] [Abstract][Full Text] [Related]
12. The use of spatial dose gradients and probability density function to evaluate the effect of internal organ motion for prostate IMRT treatment planning.
Jiang R; Barnett RB; Chow JC; Chen JZ
Phys Med Biol; 2007 Mar; 52(5):1469-84. PubMed ID: 17301465
[TBL] [Abstract][Full Text] [Related]
13. Major reduction of monitor units with the avoidance of leaf-sequencing step by direct aperture based IMRT optimisation.
Seppälä J; Lahtinen T; Kolmonen P
Acta Oncol; 2009; 48(3):426-30. PubMed ID: 18766997
[TBL] [Abstract][Full Text] [Related]
14. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
15. A feasibility study of using conventional jaws to deliver IMRT plans in the treatment of prostate cancer.
Kim Y; Verhey LJ; Xia P
Phys Med Biol; 2007 Apr; 52(8):2147-56. PubMed ID: 17404460
[TBL] [Abstract][Full Text] [Related]
16. The effect of changing technique, dose, and PTV margin on therapeutic ratio during prostate radiotherapy.
Huang SH; Catton C; Jezioranski J; Bayley A; Rose S; Rosewall T
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1057-64. PubMed ID: 18339487
[TBL] [Abstract][Full Text] [Related]
17. Study on surface dose generated in prostate intensity-modulated radiation therapy treatment.
Chow JC; Grigorov GN; Barnett RB
Med Dosim; 2006; 31(4):249-58. PubMed ID: 17134664
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications.
Zelefsky MJ; Yamada Y; Cohen GN; Sharma N; Shippy AM; Fridman D; Zaider M
Radiother Oncol; 2007 Aug; 84(2):185-9. PubMed ID: 17692978
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
